ACCENTIA BIOPHARMACEUTICALS INC 4
4 · ACCENTIA BIOPHARMACEUTICALS INC · Filed Oct 26, 2012
Insider Transaction Report
Form 4
ODONNELL FRANCIS E JR
DirectorCHAIRMAN & CEO
Transactions
- Other
Common Stock
2012-10-24−500,000→ 3,335,992 total(indirect: By LLC)
Footnotes (2)
- [F1]The subject shares, which were held indirectly by the reporting person through Hopkins Capital Group, LLC, were involuntarily transferred by Hopkins Capital Group, LLC to a lender of Hopkins Capital Partners, Inc. under a pledge and account control agreement between the lender and Hopkins Capital Partners, Inc. The lender exercised its rights to take title to such shares in exchange for a reduction in Hopkins Capital Partners, Inc.'s secured indebtedness equal to $0.12 per transferred share.
- [F2]The reporting person is the managing partner in Hopkins Capital Group, LLC and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.